Use of Dried Blood Spot Specimens to Monitor Patients with Inherited Metabolic Disorders

Monitoring of patients with inherited metabolic disorders (IMDs) using dried blood spot (DBS) specimens has been routinely used since the inception of newborn screening (NBS) for phenylketonuria in the 1960s. The introduction of flow injection analysis tandem mass spectrometry (FIA–MS/MS) in the 199...

Descripción completa

Detalles Bibliográficos
Autores principales: Moat, Stuart J., George, Roanna S., Carling, Rachel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422991/
https://www.ncbi.nlm.nih.gov/pubmed/33073023
http://dx.doi.org/10.3390/ijns6020026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422991/
https://www.ncbi.nlm.nih.gov/pubmed/33073023
http://dx.doi.org/10.3390/ijns6020026

Ejemplares similares